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illustrate the impetus that work on AAG has given to 
glycoprotein studies in general. 
The book is in four sections which vary in length and 
approach. The first section deals with the general 
biochemistry and structure of the glycoprotein through four 
reviews. A relatively brief but illuminating account of his own 
work is given by Schmid. This not only reviews the highly 
successful results of imaginative and meticulous application 
of developing methods of protein and glycan analysis. It also 
provides gliipses of the foresight and depth of co~itment 
that enabled Schmid to recognise and pursue the solution of 
important problems that were unf~hionable to his seniors in 
the ‘SOS. The structure-function relationships of the glycan 
chains of AAG are then put into context by a thorough and 
very readable review of the glycans of human plasma 
glycoproteins in general. These relationships are explored 
further in an assessment of the significance of glycan 
microheterogeneity in diseased states. An account then 
follows of the power of immunochemical approaches to 
exploring some of these areas. 
A section on the genetics of AAG commences with an 
interesting review of the genomic organisation and expression 
of several AAG genes. The two following chapters present 
data bearing on these phenomena. There then follows a dozen 
or so very brief and varied communications interspersed with 
longer chapters on drug binding to AAG and its hepatic 
elimination from the circulation by the asialoglycoprotein 
receptor. These papers generally make interesting reading and 
cover a wide range of topics. Surprisingly they appear in the 
section headed Genetics. Sadly there is very little molecular 
biology reported. 
A relatively short section headed ‘Immune Functions of 
AAG’ deals with its relationship to interleukin-1 and with 
immunochemical analyses of the glycoprotein. This is 
followed by the largest section of the book concerned mainly 
with drug-bin~ng properties, reflecting the current applied 
ph~macologic~ importance of the compound. 
On the whole this book is a readable and interesting 
account of a wide range of studies on AAG. With so many 
authors variation in depth and standard of presentation is 
inevitable. There is some imbalance in the treatment and there 
is little that is very new. However, it draws together a large 
body of information on this model glycoprotein which will be 
invaluable for any student of this fascinating group of 
compounds. The price is probably beyond all but the 
enthusiast, but in the library it is likely to be well used by 
practitioners from a wide range of life sciences. 
Frank Hemming 
Hemoglobin Switching; Edited by G. Stamatoyannopoulos and A.W. Nienhuis; AIan R. Liss; New York, 1989; 
Part A, xxvi + 378 pages; part B, xxiv + 468 pages; $120.00 each 
This two-volume work represents the proceedings of the Sixth 
‘Haemoglobin Switching Conference’, held in Arlie House, 
Virginia, in September 1988. For the uninitiat~, 
haemoglobin switching is shorthand for a characteristic 
developmental phenomenon taking place in most vertebrates, 
whereby at successive stages of ontogenesis different but 
related genes are responsible in turn for the bulk of 
haemoglobin synthesis. In humans, the greatest focus of 
interest has been on the y to fi switch, whereby in fetal life 
most of the haemoglobin is F (o&, and after birth most of 
the haemoglobin is A (cu&). From the point of view of 
molecular biology, a strong incentive to understanding the 
switch has been its perception as a model of how genes are 
turned on and off; from the point of view of clinical 
haematology, influencing the switch has been a dream- 
approach to treatment of haemoglobinopathies. 
These two books contain a total of 64 papers, plus a final 
overview by David Nathan, who met with great spirit the real 
challenge of summarizing not only this symposium, but also 
the previous five held on the same topic since 1978. In his 
discussion, enlived by a wealth of personal recollections, he 
manages to identify the continuing research threads through 
the decade which started with the cloning of the globin genes 
and finished with the identification of several critical control 
regions in the fi-globin gene cluster. 
I must admit to being prejudiced against symposia 
proceedings (perhaps betraying a feeling of guilt for not 
always bringing the expected camera-ready manuscript to 
meetings!). As a rule, they are fragmentary, and the material 
is repetitious of papers already pub~sh~ or soon to be 
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published in accredited journals. This work is an outstanding 
exception to the rule. Because the topic is so specific, and 
practically every lab working on it is well represented, the two 
volumes give an impressive, detailed and authoritative 
account of the haemoglobin switch. 
If it took Nathan about 30 pages to do his summary, I 
could certainly not presume to do it in one. One volume (part 
A) deals with Transcriptional Regulation, the other (part B) 
with Cellular and Molecular Mechanisms. Inevitably, the 
distinction between transcriptional regulation of y-globin 
genes and the molecular mechanism of the switch is rather 
blurred, but the reader is helped by the further grouping of 
papers into various sections, ranging from transcriptional 
control of individual globin genes, to comparative molecular 
genetics, to ‘chromatin and nuclear matrix’, to the genetics 
and phenogenetics of hereditary persistence of fetal 
haemoglobin (HPFH). Part B acquires its identity through 
the papers on cell lines, on HPFH mutants and on the clinical 
implications of attempting to tamper with the switch, 
especially in sickle cell anaemia. Indeed, as much as the use 
in these patients of cytotoxic agents, like azacytidine and 
hydroxyurea, might have appeared drastic and is potentially 
dangerous, one is impressed by the fact that the ploy actually 
works, at least to the extent that substantial increases in HbF 
levels are seen in a substantial proportion of patients (whether 
this will become standard treatment remains to be seen). 
The problem of the haemoglobin switch was posed since 
the early sixties and C. Baglioni (Molecular Genetics, H.C. 
Taylor, Ed., Academic Press, 1963) had already suggested 
that in normal adults haemoglobin F synthesis was influenced 
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by the rate of erythropoietic activity in the bone marrow. A 
critical view of the progress made in nearly 30 years might be 
that the switch has still not been cracked: but such a simplistic 
statement would be misleading. In fact, it has become quite 
clear that the regulatory events responsible for the 
phenomenal transcriptional activity of genes within the ,19- 
globin cluster in erythroid cells are distinct from the 
regulatory events that determine which genes within the 
cluster are predominantly expressed. The element responsible 
for the former phenomenon is the so-called c~-do~nant 
region identified by F. Grosveld’s group upstre~ of the 
embryonic (c) gene; the elements responsible for the y to @ 
switch are still elusive, although regions within the second 
intron and 3’ to the third exon seem to be good candidates. 
The role of trans-acting factors, compellingly supported by 
genetic and cellular studies, is only beginning to be clarified. 
Haemoglobin Switching could be subtitled ‘everything you 
want to know about the switch and more’. As such it can be 
recommended wholeheartedly to all those working on 
haemoglobin or in developmental biology: it is a must for 
anybody involved in both. In spite of the usual one-year gap 
between the conference and the publication, it is still 
remarkably up-to-date. I don’t know how much editing 
George Stamatoyannopoulos and Arthur Nienhuis have had 
a chance to do on the manuscripts, since the attractive pro- 
duction is a good example of complementation between 
photo-offsetting and mostly immaculate word-processor 
printouts. My impr~sion is that they have been masters of 
‘upstream editing’, which they have done by selecting the 
speakers-authors. I suspect and hope they are already apply- 
ing the same skill to organising the next conference, 
‘Haemoglobin Switching in the Nineties’. 
Lucia Luzzatto 
Glutathione: Chemical, Biochemical and Medical Aspects (Coenzymes and Cofactors, vol. 3); Edited by D, 
Dolphin, R. Poulson and 0. Avramovic; Wiley Interscience; New York, 1989; Part A, xiv + 930 pages, E88.15; 
Part B, xvi + 848 pages; E%.85 
This pair of volumes is the third in a series on coenzymes and 
cofactors; Vol. 1 (parts A and B) covered vitamin B6 and Vol. 
2 (parts A and B) the pyridine (sic) nucleotide coenzymes. The 
editors obviously intend to fill a considerable length of library 
shelving by the time they have finished with all the coen- 
zymes. I remain to be convinced that this is a useful exercise, 
or that such volumes serve a more useful purpose than brief 
critical reviews on selected aspects (which could be published 
more rapidly, and hence be more up to date), followed by 
spending the balance of the purchase price on a computer 
search of the current literature. 
This is a multi-author work, and obviously there are dif- 
ferences in the quality of different chapters. The chapter on 
glutathione in ocular tissue includes an excellent succinct 
summary of the structure and function of the lens and its 
development. As an example of the sort of irrelevant infor- 
mation I delight in collecting, I had not realised that the cen- 
tre of my lens contains cells which are as old as I am (in fact, 
older, since they developed ante-natally) - and old lens cells 
never die. By contrast, I searched the chapter on leukotriene 
C biosynthesis for the structure of a compound I was regret- 
tably unable to recall - to find it, eventually, hidden among 
12 compounds in a single small diagram. Perhaps it is the age 
of the cells at the centre of my lens which renders such 
diagrams less than satisfactory! 
The standard, quality and style of diagrams vary widely 
between chapters, suggesting that art-work provided by 
authors was used directly. While this does help to keep the 
price down, it also results in a very uneven appearance of the 
finished volumes. Where diagrams have been reproduced 
directly from primary research publications, this shows in 
very poor quality. In some chapters the diagrams are conven- 
tionally captioned, while in others it is difficult to work out 
what the diagrams are meant to convey - they are inserted in 
the text with no captions. 
Each chapter has an extensive bibliography, with several 
hundred references cited - ~fortunately without titles, so it 
is difficult to know whether a given paper is likely to reward 
a visit to the library or not. The references are cited by 
number, which occasionally leads to the rather inelegant prac- 
tice of a number followed by a, b, etc. - and not always 
where relatively recent references have been inserted in proof. 
The most recent I found was 1986! 
The most serious criticism of this book must be that there 
is more overlap between chapters than is reasonable, even in 
a multi-author work. It becomes annoying to read the same 
introductory matter several times over, but more seriously, 
different authors have used the term ‘glutathione’ with dif- 
ferent meanings - as either ‘total glutathione’ 
(= GSH + GSSG) or as ‘reduced glutathione (GSH) - despite 
comments on nomenclature from Meister in his opening 
Chapter. The editors must be taken to task for failure to edit 
the work into a consistent style. 
David A. Bender 
Sixteenth Symposium on Nucleic Acids Chemistry (Nucleic Acids Symposium Series No. 21); Organized by H. 
Takaku; IRL Press; Oxford, 1989; viii + 142 pages; f30.00 
This small book is made up of two page abstract papers 
presented at the Sixteenth S~posium on Nucleic Acids 
Chemistry which was organised by Professor Hiroshi Takaku 
and which was held at Narashino, Japan between 5th and 7th 
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